[Metabolically conditioned erythrocyte rigidity in hemodialyzed uremic patients].
D000255:Adenosine Triphosphate / Q000097:blood; D002118:Calcium / Q000097:blood; D002462:Cell Membrane; D002470:Cell Survival; D002860:Chromium Radioisotopes; D004913:Erythrocytes, Abnormal / Q000209:etiology*; D005994:Glycerophosphates / Q000097:blood; D006207:Half-Life; D006242:Haptoglobins; D006400:Hematocrit; D006461:Hemolysis; D006801:Humans; D008274:Magnesium / Q000097:blood; D009996:Osmotic Fragility; D010710:Phosphates / Q000097:blood; D006435:Renal Dialysis / Q000009:adverse effects; D013154:Spleen / Q000503:physiopathology; D013156:Splenectomy; D013435:Sulfhemoglobin / Q000378:metabolism; D014511:Uremia / Q000097:blood* / Q000150:complications
D002860:Chromium Radioisotopes; D005994:Glycerophosphates; D006242:Haptoglobins; D010710:Phosphates; D000255:Adenosine Triphosphate; D013435:Sulfhemoglobin; D008274:Magnesium; D002118:Calcium
Metabolisch bedingte Erythrozytenrigidität bei hämodialysierten urämischen Patienten